NYSE:TMOLife Sciences
Thermo Fisher (TMO) Stock Looks Fairly Valued With Earnings Overvalued
After a sharp 21.9% gain over the past month, Thermo Fisher Scientific now sits in a more finely balanced spot on price. The Discounted Cash Flow (DCF) intrinsic value suggests the stock is roughly in line with fair value, while market based multiples lean more expensive.
The 21.9% rise in the past month puts recent momentum front and center, which can leave less room for error if expectations later cool.
Recent contract wins and product launches can support expectations for future cash...

